LENZ Therapeutics, Inc.
LENZ Therapeutics commercializes VIZZ (aceclidine ophthalmic solution) 1.44%, an FDA-approved eye drop for presbyopia.
8-KSep 17Latest SEC filing, period to Sep 17
Aug 11Latest story
August 2026
July 2026
Sign inSign inLENZ Therapeutics commercializes VIZZ (aceclidine ophthalmic solution) 1.44%, an FDA-approved eye drop for presbyopia.